Akero Therapeutics: , Including Exhibit 99.1 And Exhibit 99.2 Hereto, Is Being Furnished Herewith And Shall Not Be Deemed Filed For The Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (the Exchange Act ), Or Otherwise Subject To The Liabilities Of That Section, Nor Shall Such Information Be Deemed Incorporated By Reference Into Any Filing Under The Securities Act Of 1933, As Amended (the Securities Act ), Or The Exchange Act, Except As Expressly Set Forth By Specific Reference In Such Filing, Other Events, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Akero Therapeutics Inc.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***